Analysts have provided the following ratings for Chinook Therapeutics (NASDAQ:KDNY) within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
0
2
8
0
0
Last 30D
0
0
1
0
0
1M Ago
0
0
0
0
0
2M Ago
0
0
7
0
0
3M Ago
0
2
0
0
0
These 10 analysts have an average price target of $39.0 versus the current price of Chinook Therapeutics at $39.18, implying downside.
Below is a summary of how these 10 analysts rated Chinook Therapeutics over the past 3 months. The greater the number of bullish ratings, the more positive analysts are on the stock and the greater the number of ...Full story available on Benzinga.com
Related tickers: KDNY.
Read Full Article
